PAR-25-248-Full-Announcement.html

This document is a Funding Opportunity Announcement (FOA) for a federal grant opportunity titled "Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)." The FOA is sponsored by the Department of Health and Human Services National Institutes of Health under the Cancer Cause and Prevention Research grant program (CFDA #93.393).

The FOA encourages applications that propose to advance research in cancer etiology and early detection biomarkers using the biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. Eligible applicants include higher education institutions, tribal governments, for-profit organizations, non-profits, and other entities. The proposed research projects must involve the use of PLCO biospecimens and take advantage of their unique characteristics. The FOA supports a wide range of cancer research, including biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers.